Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$735,889
in 3 filings

Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$736K Chief Legal Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-29 Hayden Michael R Director Option exercise +15,000 $6.42 $96K 95,000
2021-01-29 Hayden Michael R Director Option exercise · Stock Option (right to buy) −50,000 0
2021-01-29 Hayden Michael R Director Option exercise · Stock Option (right to buy) −30,000 0
2021-01-29 Hayden Michael R Director Option exercise · Stock Option (right to buy) −15,000 0
2021-01-28 Robertson Stephen P. EVP, General Counsel Purchase +900 $16.14 $15K 2,720

Page 18 of 18 · 345 trades